ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME
申请人:Nogra Pharma Limited
公开号:US20170158707A1
公开(公告)日:2017-06-08
The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity, methods of treating inflammatory conditions such as Crohn's disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-γ in a subject.